These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1804882)
1. Prognostic value of the lepromin test in contacts of leprosy cases. 1955. Dharmendra ; Chatterjee KR Indian J Lepr; 1991; 63(3-4):293-6. PubMed ID: 1804882 [No Abstract] [Full Text] [Related]
2. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study. Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the lepromin test--further information on the subject. Dharmendra Indian J Lepr; 1989 Jul; 61(3):387-90. PubMed ID: 2768886 [No Abstract] [Full Text] [Related]
4. Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w. Sharma P; Kar HK; Kaur H; Misra RS; Mukherjee A; Mukherjee R; Rani R Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):136-42. PubMed ID: 11036493 [TBL] [Abstract][Full Text] [Related]
5. Comment: Positive Mitsuda lepromin reaction in long-term treated lepromatous leprosy and tuberculoid relapse in lepromatous leprosy. Walter J Lepr Rev; 1991 Dec; 62(4):434-6. PubMed ID: 1845302 [No Abstract] [Full Text] [Related]
6. SEARCH FOR HUMORAL ANTIBODY IN SERUM IN LEPROMATOUS LEPROSY. BARUA D; GHOSH S; MUKERJEE N; BANERJEE R; BOSE R Bull Calcutta Sch Trop Med; 1963 Apr; 11():61-3. PubMed ID: 14301730 [No Abstract] [Full Text] [Related]
7. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis. Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of cell mediated immunity in healthy contacts of leprosy. Kurhade AM; Akulwar SL; Pathak AA; Thakar YS; Dhanvijay AG Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148 [TBL] [Abstract][Full Text] [Related]
9. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report. Kar BR; Job CK Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213 [TBL] [Abstract][Full Text] [Related]
10. A study of lepromin reaction in child contacts of leprosy patients and non contact children in Chengalpattu District Tamil Nadu. Ramu G; Dwivedi MP; Iyer CG Lepr India; 1980 Jul; 52(3):390-404. PubMed ID: 7206635 [TBL] [Abstract][Full Text] [Related]
11. CLINICAL EVALUATION STUDIES IN LEPROMATOUS LEPROSY. FIFTH SERIES: DIETHYL DITHIOLISOPHTHALATE (ETISUL) AS A SUPPLEMENT TO 4-4' DIAMINODIPHENYL SULFONE (DDS). DOULL JA; TOLENTINO JG; RODRIGUEZ JN; GUINTO RS; RIVERA JN; FERNANDEZ JV; MABALAY MC Int J Lepr; 1965; 33():186-205. PubMed ID: 14339337 [No Abstract] [Full Text] [Related]
12. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents. Foss NT; Pagnano PM; Bechelli LM; Simoes AL Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296 [TBL] [Abstract][Full Text] [Related]
13. Prospective immunological follow-up in household contacts of Mexican leprosy patients. Amezcua ME; Escobar-Gutiérrez A; Barba-Rubio J; Cázares JV; Mayén E; Chávez-Núñez M; Peña RC; Rodríguez R; Pastén S Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115 [TBL] [Abstract][Full Text] [Related]
14. [The lymphocyte transformation test using phytohemagglutinin, lepromin and M. leprae in lepromin-negative and positive leprosy: prognostic value compared with that of lepromin]. Pagnano PM; Bechelli LM; de Lima Filho EC Acta Leprol; 1982; (86-87):83-95. PubMed ID: 6816002 [No Abstract] [Full Text] [Related]
15. Induction of lepromin reactivity in cured lepromatous leprosy patients: impaired chemokine response dissociates protective immunity from delayed type hypersensitivity. Mitra DK; Joshi B; Dinda AK; Rai AK; Girdhar BK; Katoch K; Bindra MS; Sengupta U Microbes Infect; 2009 Dec; 11(14-15):1122-30. PubMed ID: 19703581 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial). Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110 [TBL] [Abstract][Full Text] [Related]
17. The blind man and the paralytic boy of lesnovo: diagnosis of borderline lepromatous leprosy after 660 years? V'lckova-Laskoska MT; Laskoski DS Arch Dermatol; 2009 Sep; 145(9):1047. PubMed ID: 19770447 [No Abstract] [Full Text] [Related]
18. The post-lepromin scar and its significance in the control of HD. Walter J Indian J Lepr; 1989 Jul; 61(3):379-86. PubMed ID: 2527921 [TBL] [Abstract][Full Text] [Related]
19. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs. Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443 [TBL] [Abstract][Full Text] [Related]
20. IL-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy. Launois P; Vandenbussche P; M'Bayame NN; Drowart A; Van Vooren JP; Sarthou JL; Millan J; Huygen K Cell Immunol; 1993 May; 148(2):283-90. PubMed ID: 8495494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]